12:00 AM
Jul 01, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

Galectin Therapeutics management update

Galectin Therapeutics Inc. (NASDAQ:GALT), Norcross, Ga.
Business: Cancer, Drug...

Read the full 25 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >